Amyotrophic lateral sclerosis: from pathological mechanisms to patient care G. Scarlato Foreword Pages: S1 - S2
Glutamate, excitotoxicity and amyotrophic lateral sclerosis P. J. ShawP. G. Ince OriginalPaper Pages: S3 - S14
Transgenic animal models of familial amyotrophic lateral sclerosis Mark E. Gurney OriginalPaper Pages: S15 - S20
The amyotrophic lateral sclerosis health state scale and the effect of riluzole T. L. Munsat BriefCommunication Pages: S21 - S21
The Riluzole Early Access Programme: descriptive analysis of 844 patients in France Vincent MeiningerMichel DibPhilippe Zeisser OriginalPaper Pages: S22 - S25
Health outcome and quality-of-life measurements in amyotrophic lateral sclerosis Michael Swash OriginalPaper Pages: S26 - S29
Impact of riluzole on the relationship between patient and physician R. DenglerM. Tröger OriginalPaper Pages: S30 - S32